SCHEMBL29505051

SCHEMBL29505051

CON(C)C(=O)c1cccc(C)c1Nc1cccc(C(F)(F)F)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAPGEF4 Q8WZA2 1/20 0.51
▸ RXFP1 Q9HBX9 5/20 0.47
▸ TP53 P04637 1/20 0.47
▸ AKR1C3 P42330 1/20 0.47
▸ AKR1C2 P52895 1/20 0.47
▸ LMNA P02545 4/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ P2RX1 P51575 1/20 0.46
▸ POLB P06746 2/20 0.44
▸ TEAD4 Q15561 2/20 0.44
▸ CYP1A2 P05177 2/20 0.44
▸ CYP3A4 P08684 2/20 0.44
▸ GMNN O75496 1/20 0.44
▸ TTR P02766 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ PKM P14618 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22719694 1.00 RAPGEF4 (0.51) RAPGEF4RXFP1TP53AKR1C3AKR1C2
SCHEMBL22719798 0.84 RAPGEF4 (0.57) RAPGEF4RXFP1AKR1C3AKR1C2LMNA
SCHEMBL22719750 0.82 MEN1 (0.60) RAPGEF4RXFP1AKR1C3AKR1C2LMNA
SCHEMBL29505067 0.82 RAPGEF4 (0.59) RAPGEF4RXFP1AKR1C3AKR1C2LMNA
SCHEMBL22719651 0.82 RAPGEF4 (0.59) RAPGEF4RXFP1AKR1C3AKR1C2LMNA
SCHEMBL25391251 0.80 LMNA (0.68) LMNASMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL29504944 0.78 MPO (0.68) RXFP1TP53AKR1C3AKR1C2LMNA
SCHEMBL22719735 0.78 MPO (0.68) RXFP1TP53AKR1C3AKR1C2LMNA
SCHEMBL22719664 0.78 TEAD4 (0.68) RAPGEF4RXFP1AKR1C3AKR1C2LMNA
SCHEMBL29505150 0.78 TEAD4 (0.68) RAPGEF4RXFP1AKR1C3AKR1C2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3976192-A1 TEAD INHIBITORS AND USES THEREOF Ikena Oncology, Inc. (US) 2022-04-06 — — EP disclosed
Send feedback